Table 5.
Adjusted odds ratios for TFL versus HL, selected outcomes
| OR | 95% CI | P | |
|---|---|---|---|
| Incontinence (all types and duration) | |||
| Model 1 | 0.655 | 0.446–0.958 | 0.030 |
| Model 2 | 0.427 | 0.251–0.719 | 0.002 |
| Model 3 (PSM) | 0.765 | 0.483–1.204 | 0.249 |
| Model 4 (PSM, additional adjustment) | 0.520 | 0.292–0.918 | 0.025 |
| 30-day complications | |||
| Model 1 | 1.231 | 0.826–1.842 | 0.308 |
| Model 2 | 2.216 | 1.243–4.043 | 0.008 |
| Model 3 (PSM) | 1.430 | 0.887–2.340 | 0.144 |
| Model 4 (PSM, additional adjustment) | 1.413 | 0.756–2.708 | 0.286 |
Model 1: adjusted for age, prostate volume, preoperative indwelling catheter, preoperative IPSS, preoperative Qmax, preoperative PVRU.
Model 2: adjusted for covariates in model 1 plus enucleation type, early apical release, and total operation time.
Model 3: propensity score-matched model.
Model 4: propensity score-matched model with correction for significant covariates.
HL, holmium laser; OR, odds ratio; PSM; propensity score matched; TFL, thulium fiber laser.